{
  "DOI": "10.1186/s40246-023-00524-1",
  "ISSN": [
    "1479-7364"
  ],
  "URL": "http://dx.doi.org/10.1186/s40246-023-00524-1",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eBackground\u003c/jats:title\u003e\n                \u003cjats:p\u003eDiagnostic efficacy is now well established for diagnostic genomic testing in rare disease. Assessment of overall utility is emerging as a key next step, however ambiguity in the conceptualisation and measurement of utility has impeded its assessment in a comprehensive manner. We propose a conceptual framework to approach determining the broader utility of diagnostic genomics encompassing patients, families, clinicians, health services and health systems to assist future evidence generation and funding decisions.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eBody\u003c/jats:title\u003e\n                \u003cjats:p\u003eBuilding upon previous work, our framework posits that utility of diagnostic genomics consists of three dimensions: the domain or type and extent of utility (what), the relationship and perspective of utility (who), and the time horizon of utility (when). Across the description, assessment, and summation of these three proposed dimensions of utility, one could potentially triangulate a singular point of utility axes of type, relationship, and time. Collectively, the multiple different points of individual utility might be inferred to relate to a concept of aggregate utility.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eConclusion\u003c/jats:title\u003e\n                \u003cjats:p\u003eThis ontological framework requires retrospective and prospective application to enable refinement and validation. Moving forward our framework, and others which have preceded it, promote a better characterisation and description of genomic utility to inform decision-making and optimise the benefits of genomic diagnostic testing.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e",
  "alternative-id": [
    "524"
  ],
  "article-number": "75",
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "9 June 2023"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "9 August 2023"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "16 August 2023"
    },
    {
      "group": {
        "label": "Declarations",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Ethics approval and consent to participate",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "Not applicable."
    },
    {
      "group": {
        "label": "Consent for publication",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 3,
      "value": "Not applicable."
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 4,
      "value": "AJM is a recipient of a Queensland Health Advancing Clinical Research Fellowship."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Mallett",
      "given": "Andrew",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Stark",
      "given": "Zornitza",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Fehlberg",
      "given": "Zoe",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Best",
      "given": "Stephanie",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Goranitis",
      "given": "Ilias",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Human Genomics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2023,
        8,
        16
      ]
    ],
    "date-time": "2023-08-16T15:01:48Z",
    "timestamp": 1692198108000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        11,
        19
      ]
    ],
    "date-time": "2023-11-19T06:10:28Z",
    "timestamp": 1700374228000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        4,
        26
      ]
    ],
    "date-time": "2024-04-26T23:34:36Z",
    "timestamp": 1714174476151
  },
  "is-referenced-by-count": 5,
  "issn-type": [
    {
      "type": "electronic",
      "value": "1479-7364"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2023,
        8,
        16
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-online": {
      "date-parts": [
        [
          2023,
          12
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2023,
            8,
            16
          ]
        ],
        "date-time": "2023-08-16T00:00:00Z",
        "timestamp": 1692144000000
      }
    },
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2023,
            8,
            16
          ]
        ],
        "date-time": "2023-08-16T00:00:00Z",
        "timestamp": 1692144000000
      }
    }
  ],
  "link": [
    {
      "URL": "https://link.springer.com/content/pdf/10.1186/s40246-023-00524-1.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/article/10.1186/s40246-023-00524-1/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/content/pdf/10.1186/s40246-023-00524-1.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "prefix": "10.1186",
  "published": {
    "date-parts": [
      [
        2023,
        8,
        16
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2023,
        8,
        16
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1038/s41525-018-0053-8",
      "author": "MM Clark",
      "doi-asserted-by": "publisher",
      "first-page": "16",
      "journal-title": "NPJ Genom Med",
      "key": "524_CR1",
      "unstructured": "Clark MM, Stark Z, Farnaes L, Tan TY, White SM, Dimmock D, Kingsmore SF. Meta-analysis of the diagnostic and clinical utility of genome and exome sequencing and chromosomal microarray in children with suspected genetic diseases. NPJ Genom Med. 2018;3:16.",
      "volume": "3",
      "year": "2018"
    },
    {
      "DOI": "10.1016/j.ajhg.2023.01.018",
      "author": "Z Stark",
      "doi-asserted-by": "publisher",
      "first-page": "419",
      "issue": "3",
      "journal-title": "Am J Hum Genet",
      "key": "524_CR2",
      "unstructured": "Stark Z, Boughtwood T, Haas M, Braithwaite J, Gaff CL, Goranitis I, Spurdle AB, Hansen DP, Hofmann O, Laing N, et al. Australian genomics: outcomes of a 5-year national program to accelerate the integration of genomics in healthcare. Am J Hum Genet. 2023;110(3):419–26.",
      "volume": "110",
      "year": "2023"
    },
    {
      "DOI": "10.1186/s13073-021-00855-5",
      "author": "H Stranneheim",
      "doi-asserted-by": "publisher",
      "first-page": "40",
      "issue": "1",
      "journal-title": "Genome Med",
      "key": "524_CR3",
      "unstructured": "Stranneheim H, Lagerstedt-Robinson K, Magnusson M, Kvarnung M, Nilsson D, Lesko N, Engvall M, Anderlid BM, Arnell H, Johansson CB, et al. Integration of whole genome sequencing into a healthcare setting: high diagnostic rates across multiple clinical entities in 3219 rare disease patients. Genome Med. 2021;13(1):40.",
      "volume": "13",
      "year": "2021"
    },
    {
      "DOI": "10.1056/NEJMoa2035790",
      "author": "GPP Investigators",
      "doi-asserted-by": "publisher",
      "first-page": "1868",
      "issue": "20",
      "journal-title": "N Engl J Med",
      "key": "524_CR4",
      "unstructured": "Investigators GPP, Smedley D, Smith KR, Martin A, Thomas EA, McDonagh EM, Cipriani V, Ellingford JM, Arno G, Tucci A, et al. 100,000 Genomes pilot on rare-disease diagnosis in health care—preliminary report. N Engl J Med. 2021;385(20):1868–80.",
      "volume": "385",
      "year": "2021"
    },
    {
      "DOI": "10.1038/s41431-023-01417-6",
      "doi-asserted-by": "publisher",
      "key": "524_CR5",
      "unstructured": "Mordaunt DA, Dalziel K, Goranitis I, Stark Z. Uptake of funded genomic testing for syndromic and non-syndromic intellectual disability in Australia. Eur J Hum Genet. 2023. https://doi.org/10.1038/s41431-023-01417-6."
    },
    {
      "DOI": "10.1038/gim.2016.186",
      "author": "B Lerner",
      "doi-asserted-by": "publisher",
      "first-page": "763",
      "issue": "7",
      "journal-title": "Genet Med",
      "key": "524_CR6",
      "unstructured": "Lerner B, Marshall N, Oishi S, Lanto A, Lee M, Hamilton AB, Yano EM, Scheuner MT. The value of genetic testing: beyond clinical utility. Genet Med. 2017;19(7):763–71.",
      "volume": "19",
      "year": "2017"
    },
    {
      "DOI": "10.1097/01.gim.0000227935.26763.c6",
      "author": "SD Grosse",
      "doi-asserted-by": "publisher",
      "first-page": "448",
      "issue": "7",
      "journal-title": "Genet Med",
      "key": "524_CR7",
      "unstructured": "Grosse SD, Khoury MJ. What is the clinical utility of genetic testing? Genet Med. 2006;8(7):448–50.",
      "volume": "8",
      "year": "2006"
    },
    {
      "DOI": "10.1097/GIM.0b013e3181837217",
      "author": "SD Grosse",
      "doi-asserted-by": "publisher",
      "first-page": "648",
      "issue": "9",
      "journal-title": "Genet Med",
      "key": "524_CR8",
      "unstructured": "Grosse SD, Wordsworth S, Payne K. Economic methods for valuing the outcomes of genetic testing: beyond cost-effectiveness analysis. Genet Med. 2008;10(9):648–54.",
      "volume": "10",
      "year": "2008"
    },
    {
      "DOI": "10.1097/GIM.0b013e3181af0a80",
      "author": "SD Grosse",
      "doi-asserted-by": "publisher",
      "first-page": "575",
      "issue": "8",
      "journal-title": "Genet Med",
      "key": "524_CR9",
      "unstructured": "Grosse SD, McBride CM, Evans JP, Khoury MJ. Personal utility and genomic information: look before you leap. Genet Med. 2009;11(8):575–6.",
      "volume": "11",
      "year": "2009"
    },
    {
      "DOI": "10.1038/s41436-020-0809-2",
      "author": "I Goranitis",
      "doi-asserted-by": "publisher",
      "first-page": "1311",
      "issue": "8",
      "journal-title": "Genet Med",
      "key": "524_CR10",
      "unstructured": "Goranitis I, Best S, Christodoulou J, Stark Z, Boughtwood T. The personal utility and uptake of genomic sequencing in pediatric and adult conditions: eliciting societal preferences with three discrete choice experiments. Genet Med. 2020;22(8):1311–9.",
      "volume": "22",
      "year": "2020"
    },
    {
      "DOI": "10.1038/s41436-020-00949-2",
      "author": "I Goranitis",
      "doi-asserted-by": "publisher",
      "first-page": "155",
      "issue": "1",
      "journal-title": "Genet Med",
      "key": "524_CR11",
      "unstructured": "Goranitis I, Best S, Stark Z, Boughtwood T, Christodoulou J. The value of genomic sequencing in complex pediatric neurological disorders: a discrete choice experiment. Genet Med. 2021;23(1):155–62.",
      "volume": "23",
      "year": "2021"
    },
    {
      "DOI": "10.1038/s41431-021-00874-1",
      "author": "I Goranitis",
      "doi-asserted-by": "publisher",
      "first-page": "1645",
      "issue": "11",
      "journal-title": "Eur J Hum Genet",
      "key": "524_CR12",
      "unstructured": "Goranitis I, Best S, Christodoulou J, Boughtwood T, Stark Z. Preferences and values for rapid genomic testing in critically ill infants and children: a discrete choice experiment. Eur J Hum Genet. 2021;29(11):1645–53.",
      "volume": "29",
      "year": "2021"
    },
    {
      "DOI": "10.1038/s41436-020-00963-4",
      "author": "K Jayasinghe",
      "doi-asserted-by": "publisher",
      "first-page": "183",
      "issue": "1",
      "journal-title": "Genet Med",
      "key": "524_CR13",
      "unstructured": "Jayasinghe K, Stark Z, Kerr PG, Gaff C, Martyn M, Whitlam J, Creighton B, Donaldson E, Hunter M, Jarmolowicz A, et al. Clinical impact of genomic testing in patients with suspected monogenic kidney disease. Genet Med. 2021;23(1):183–91.",
      "volume": "23",
      "year": "2021"
    },
    {
      "DOI": "10.1016/j.gim.2022.01.013",
      "author": "I Goranitis",
      "doi-asserted-by": "publisher",
      "first-page": "1037",
      "issue": "5",
      "journal-title": "Genet Med",
      "key": "524_CR14",
      "unstructured": "Goranitis I, Wu Y, Lunke S, White SM, Tan TY, Yeung A, Hunter MF, Martyn M, Gaff C, Stark Z. Is faster better? An economic evaluation of rapid and ultra-rapid genomic testing in critically ill infants and children. Genet Med. 2022;24(5):1037–44.",
      "volume": "24",
      "year": "2022"
    },
    {
      "DOI": "10.1038/s41431-021-00916-8",
      "author": "Y Wu",
      "doi-asserted-by": "publisher",
      "first-page": "577",
      "issue": "5",
      "journal-title": "Eur J Hum Genet",
      "key": "524_CR15",
      "unstructured": "Wu Y, Balasubramaniam S, Rius R, Thorburn DR, Christodoulou J, Goranitis I. Genomic sequencing for the diagnosis of childhood mitochondrial disorders: a health economic evaluation. Eur J Hum Genet. 2022;30(5):577–86.",
      "volume": "30",
      "year": "2022"
    },
    {
      "DOI": "10.1016/j.gim.2023.100942",
      "doi-asserted-by": "publisher",
      "key": "524_CR16",
      "unstructured": "Wu Y, Jayasinghe K, Stark Z, Quinlan C, Patel C, McCarthy H, Mallawaarachchi AC, Kerr PG, Alexander S, Mallett AJ et al. Genomic testing for suspected monogenic kidney disease in children and adults: a health economic evaluation. Genet Med. 2023:100942. https://doi.org/10.1016/j.gim.2023.100942."
    },
    {
      "DOI": "10.1016/j.jval.2018.06.010",
      "author": "DA Regier",
      "doi-asserted-by": "publisher",
      "first-page": "1043",
      "issue": "9",
      "journal-title": "Value Health",
      "key": "524_CR17",
      "unstructured": "Regier DA, Weymann D, Buchanan J, Marshall DA, Wordsworth S. Valuation of health and nonhealth outcomes from next-generation sequencing: approaches, challenges, and solutions. Value Health. 2018;21(9):1043–7.",
      "volume": "21",
      "year": "2018"
    },
    {
      "DOI": "10.1038/s41431-019-0452-z",
      "author": "J Buchanan",
      "doi-asserted-by": "publisher",
      "first-page": "1639",
      "issue": "11",
      "journal-title": "Eur J Hum Genet",
      "key": "524_CR18",
      "unstructured": "Buchanan J, Blair E, Thomson KL, Ormondroyd E, Watkins H, Taylor JC, Wordsworth S. Do health professionals value genomic testing? A discrete choice experiment in inherited cardiovascular disease. Eur J Hum Genet. 2019;27(11):1639–48.",
      "volume": "27",
      "year": "2019"
    },
    {
      "author": "RZ Hayeems",
      "first-page": "1096",
      "issue": "10",
      "journal-title": "J Manag Care Spec Pharm",
      "key": "524_CR19",
      "unstructured": "Hayeems RZ, Luca S, Pullenayegum E, Meyn MS, Ungar WJ. Genome diagnostics: novel strategies for measuring value. J Manag Care Spec Pharm. 2019;25(10):1096–101.",
      "volume": "25",
      "year": "2019"
    },
    {
      "DOI": "10.1038/s41436-019-0620-0",
      "author": "RZ Hayeems",
      "doi-asserted-by": "publisher",
      "first-page": "95",
      "issue": "1",
      "journal-title": "Genet Med",
      "key": "524_CR20",
      "unstructured": "Hayeems RZ, Luca S, Ungar WJ, Bhatt A, Chad L, Pullenayegum E, Meyn MS. The development of the Clinician-reported Genetic testing Utility InDEx (C-GUIDE): a novel strategy for measuring the clinical utility of genetic testing. Genet Med. 2020;22(1):95–101.",
      "volume": "22",
      "year": "2020"
    },
    {
      "DOI": "10.1016/j.gim.2021.10.005",
      "author": "RZ Hayeems",
      "doi-asserted-by": "publisher",
      "first-page": "430",
      "issue": "2",
      "journal-title": "Genet Med",
      "key": "524_CR21",
      "unstructured": "Hayeems RZ, Luca S, Ungar WJ, Venkataramanan V, Tsiplova K, Bashir NS, Costain G, Inglese C, McNiven V, Quercia N, et al. The Clinician-reported Genetic testing Utility InDEx (C-GUIDE): preliminary evidence of validity and reliability. Genet Med. 2022;24(2):430–8.",
      "volume": "24",
      "year": "2022"
    },
    {
      "DOI": "10.1038/s41431-022-01192-w",
      "author": "RZ Hayeems",
      "doi-asserted-by": "publisher",
      "first-page": "1423",
      "issue": "12",
      "journal-title": "Eur J Hum Genet",
      "key": "524_CR22",
      "unstructured": "Hayeems RZ, Luca S, Hurst ACE, Cochran M, Owens C, Hossain A, Chad L, Meyn MS, Pullenayegum E, Ungar WJ, et al. Applying the Clinician-reported Genetic testing Utility InDEx (C-GUIDE) to genome sequencing: further evidence of validity. Eur J Hum Genet. 2022;30(12):1423–31.",
      "volume": "30",
      "year": "2022"
    },
    {
      "DOI": "10.1038/s41431-020-0576-1",
      "author": "S Best",
      "doi-asserted-by": "publisher",
      "first-page": "866",
      "issue": "7",
      "journal-title": "Eur J Hum Genet",
      "key": "524_CR23",
      "unstructured": "Best S, Stark Z, Phillips P, Wu Y, Long JC, Taylor N, Braithwaite J, Christodoulou J, Goranitis I. Clinical genomic testing: what matters to key stakeholders? Eur J Hum Genet. 2020;28(7):866–73.",
      "volume": "28",
      "year": "2020"
    },
    {
      "DOI": "10.1001/jamanetworkopen.2022.25988",
      "author": "HS Smith",
      "doi-asserted-by": "publisher",
      "first-page": "e2225988",
      "issue": "8",
      "journal-title": "JAMA Netw Open",
      "key": "524_CR24",
      "unstructured": "Smith HS. Genomic medicine’s critical outcome measure-utility. JAMA Netw Open. 2022;5(8):e2225988.",
      "volume": "5",
      "year": "2022"
    },
    {
      "DOI": "10.1007/s40271-021-00558-4",
      "author": "HS Smith",
      "doi-asserted-by": "publisher",
      "first-page": "317",
      "issue": "3",
      "journal-title": "Patient",
      "key": "524_CR25",
      "unstructured": "Smith HS, Morain SR, Robinson JO, Canfield I, Malek J, Rubanovich CK, Bloss CS, Ackerman SL, Biesecker B, Brothers KB, et al. Perceived utility of genomic sequencing: qualitative analysis and synthesis of a conceptual model to inform patient-centered instrument development. Patient. 2022;15(3):317–28.",
      "volume": "15",
      "year": "2022"
    },
    {
      "DOI": "10.1007/s40273-021-01103-9",
      "author": "Y Meng",
      "doi-asserted-by": "publisher",
      "first-page": "215",
      "issue": "2",
      "journal-title": "Pharmacoeconomics",
      "key": "524_CR26",
      "unstructured": "Meng Y, Clarke PM, Goranitis I. The value of genomic testing: a contingent valuation across six child- and adult-onset genetic conditions. Pharmacoeconomics. 2022;40(2):215–23.",
      "volume": "40",
      "year": "2022"
    },
    {
      "DOI": "10.1038/s41436-019-0674-z",
      "author": "SD Grosse",
      "doi-asserted-by": "publisher",
      "first-page": "280",
      "issue": "2",
      "journal-title": "Genet Med",
      "key": "524_CR27",
      "unstructured": "Grosse SD, Rasmussen SA. Exome sequencing: value is in the eye of the beholder. Genet Med. 2020;22(2):280–2.",
      "volume": "22",
      "year": "2020"
    },
    {
      "DOI": "10.1007/s12687-016-0260-x",
      "author": "CM Halverson",
      "doi-asserted-by": "publisher",
      "first-page": "145",
      "issue": "2",
      "journal-title": "J Community Genet",
      "key": "524_CR28",
      "unstructured": "Halverson CM, Clift KE, McCormick JB. Was it worth it? Patients’ perspectives on the perceived value of genomic-based individualized medicine. J Community Genet. 2016;7(2):145–52.",
      "volume": "7",
      "year": "2016"
    },
    {
      "DOI": "10.1007/s12687-017-0314-8",
      "author": "R Hylind",
      "doi-asserted-by": "publisher",
      "first-page": "19",
      "issue": "1",
      "journal-title": "J Community Genet",
      "key": "524_CR29",
      "unstructured": "Hylind R, Smith M, Rasmussen-Torvik L, Aufox S. Great expectations: patient perspectives and anticipated utility of non-diagnostic genomic-sequencing results. J Community Genet. 2018;9(1):19–26.",
      "volume": "9",
      "year": "2018"
    },
    {
      "DOI": "10.1038/s41436-019-0601-3",
      "author": "H Stevens Smith",
      "doi-asserted-by": "publisher",
      "first-page": "69",
      "issue": "1",
      "journal-title": "Genet Med",
      "key": "524_CR30",
      "unstructured": "Stevens Smith H, Russell HV, Lee BH, Morain SR, and the Value of Exome Sequencing Delphi P. Using the Delphi method to identify clinicians’ perceived importance of pediatric exome sequencing results. Genet Med. 2020;22(1):69–76.",
      "volume": "22",
      "year": "2020"
    },
    {
      "author": "Pharmaceutical Benefits Advisory Committee (PBAC)",
      "edition": "5.0",
      "key": "524_CR31",
      "unstructured": "Pharmaceutical Benefits Advisory Committee (PBAC). Guidelines for preparing submissions to the Pharmaceutical Benefits Advisory Committee. 5.0. Canberra: Australian Government Department of Health; 2016.",
      "volume-title": "Guidelines for preparing submissions to the Pharmaceutical Benefits Advisory Committee",
      "year": "2016"
    },
    {
      "DOI": "10.1038/gim.2015.30",
      "author": "S Richards",
      "doi-asserted-by": "publisher",
      "first-page": "405",
      "issue": "5",
      "journal-title": "Genet Med",
      "key": "524_CR32",
      "unstructured": "Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405–24.",
      "volume": "17",
      "year": "2015"
    }
  ],
  "reference-count": 32,
  "references-count": 32,
  "resource": {
    "primary": {
      "URL": "https://humgenomics.biomedcentral.com/articles/10.1186/s40246-023-00524-1"
    }
  },
  "score": 0,
  "short-container-title": [
    "Hum Genomics"
  ],
  "source": "Crossref",
  "title": [
    "Determining the utility of diagnostic genomics: a conceptual framework"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "17"
}